722
S. Song et al. · Synthesis of Phthalazinetrione Derivatives
134.53, 133.57, 132.21, 132.17, 128.99, 128.93, 128.88, 3,3-Dimethyl-13-phenyl-3,4-dihydro-1H-indazolo[1,2-
127.97, 127.65, 118.15, 115.80, 115.51, 64.23, 50.86, 37.98, b]phthalazine-1,6,11(2H,13H)-trione (4a8)
34.60, 28.62, 28.40.
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.35–
8.27 (2H, m, Ph), 7.85 (2H, m, Ph), 7.40–7.27 (5H, m, Ph),
6.45 (1H, s, CHN), 3.45–3.21 (2H, AB system, J = 19.06 Hz,
13-(4-Chlorophenyl)-3,3-dimethyl-3,4-dihydro-1H-
indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione (4a4)
CHaHbCO), 2.33 (2H, s, CH2C), 1.21 (6H, s, 2-Me). –
13C NMR (75 MHz, CDCl3): δ = 192.02, 155.98, 154.23,
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.34–
8.25 (2H, m, Ph), 7.85 (2H, m, Ph), 7.37–7.28 (4H, m, Ph),
6.40 (1H, s, CHN), 3.43–3.20 (2H, AB system, J = 19.10 Hz,
CHaHbCO), 2.33 (2H, s, CH2C), 1.20 (6H, s, 2-Me). –
13C NMR (75 MHz, CDCl3): δ = 192.06, 155.96, 154.34,
150.95, 134.52, 133.56, 132.22, 132.17, 128.99, 128.95,
128.91, 128.87, 127.97, 127.65, 118.16, 115.80, 115.50,
64.23, 50.88, 37.99, 34.59, 28.62, 28.40.
150.79, 136.36, 134.43, 133.45, 129.05, 128.94, 128.64,
128.61, 127.90, 127.67, 127.07, 118.55, 64.91, 50.91, 38.00,
34.58, 28.63, 28.40.
3,3-Dimethyl-13-p-tolyl-3,4-dihydro-1H-indazolo[1,2-
b]phthalazine-1,6,11(2H,13H)-trione (4a9)
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.35–
8.27 (2H, m, Ph), 7.84 (2H, m, Ph), 7.31–7.29 (2H, m,
Ph), 7.15–7.12 (2H, m, Ph), 6.42 (1H, s, CHN), 3.45–3.20
(2H, AB system, J = 19.02 Hz, CHaHbCO), 2.33 (2H, s,
CH2C), 2.29 (3H, s, Me), 1.21 (6H, s, 2-Me). – 13C NMR
(75 MHz, CDCl3): δ = 192.08, 155.99, 154.19, 150.68,
138.42, 134.38, 133.39, 129.39, 129.12, 128.94, 127.86,
127.66, 127.01, 118.64, 64.79, 50.92, 38.01, 34.58, 28.64,
28.40, 21.15.
13-(2-Chlorophenyl)-3,3-dimethyl-3,4-dihydro-1H-
indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione (4a5)
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.37–
8.24 (2H, m, Ph), 7.85–7.84 (2H, m, Ph), 7.49–7.47 (1H, m,
Ph), 7.33–7.29 (2H, m, Ph), 7.23–7.21 (1H, m, Ph), 6.68
(1H, s, CHN), 3.44–3.20 (2H, AB system, J = 19.09 Hz,
CHaHbCO), 2.32 (2H, s, CH2C) 1.21 (6H, s, 2-Me). –
13C NMR (75 MHz, CDCl3): δ = 192.05, 156.11, 154.17,
151.80, 134.47, 133.53, 132.96, 132.51, 130.47, 129.82,
128.98, 128.65, 127.97, 127.61, 127.16, 125.65, 116.60,
64.01, 50.80, 37.96, 34.54, 28.74, 28.34.
13-Ethyl-3,3-dimethyl-3,4-dihydro-1H-indazolo[1,2-
b]phthalazine-1,6,11(2H,13H)-trione (4a10)
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.38–
8.33 (2H, m, Ph), 7.93–7.84 (2H, m, Ph), 5.72 (1H, s, CHN),
3.38–3.11 (2H, AB system, J = 19.15 Hz, CHaHbCO), 2.59–
2.50 (1H, m, CH), 2.39 (2H, s, CH2C), 2.19–2.10 (1H, m,
CH), 1.23–1.20 (6H, s, 2-Me), 0.77–0.72 (3H, t, Me). –
13C NMR (75 MHz, CDCl3): δ = 193.01, 156.02, 154.66,
151.84, 134.41, 133.37, 128.94, 128.83, 127.83, 127.45,
116.64, 63.43, 50.93, 38.02, 34.43, 28.79, 28.32, 22.05, 7.21.
13-(4-Bromophenyl)-3,3-dimethyl-3,4-dihydro-1H-
indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione (4a6)
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.35–
8.27, 7.86 (4H, m, Ph), 7.47–7.28 (4H, m, Ph), 6.40
(1H, s, CHN), 3.43–3.20 (2H, AB system, J = 19.09 Hz,
CHaHbCO), 2.33 (2H, s, CH2C), 1.20 (6H, s, 2-Me). –
13C NMR (75 MHz, CDCl3): δ = 192.04, 155.93, 154.33,
151.09, 135.44, 134.57, 133.63, 131.84, 128.88, 128.84,
128.77, 128.00, 127.66, 122.69, 117.92, 64.33, 50.83, 37.97,
34.61, 28.64, 28.36.
13-Butyl-3,3-dimethyl-3,4-dihydro-1H-indazolo[1,2-
b]phthalazine-1,6,11(2H,13H)-trione (4a11)
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.38–
8.32 (2H, m, Ph), 7.92–7.83 (2H, m, Ph), 5.70 (1H, s, CHN),
3.36–3.10 (2H, AB system, J = 19.25 Hz, CHaHbCO), 2.44–
2.38 (3H, m), 2.12–2.03 (1H, m), 1.22–1.10 (8H, m), 0.89–
0.84 (3H, t, Me). – 13C NMR (75 MHz, CDCl3): δ = 193.00,
156.02, 154.66, 151.56, 134.39, 133.34, 128.95, 128.82,
127.80, 127.45, 117.22, 62.77, 50.93, 37.98, 34.40, 31.46,
28.69, 28.39, 16.69, 13.67.
13-(2,3-Dichlorophenyl)-3,3-dimethyl-3,4-dihydro-1H-
indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione (4a7)
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.37–
13-(4-Nitrophenyl)-3,4-dihydro-1H-indazolo[1,2-
b]phthalazine-1,6,11(2H,13H)-trione (4b1)
7.26 (7H, m, Ph), 6.70 (1H, s, CHN), 3.43–3.21 (2H, AB
system, J = 17.98 Hz, CHaHbCO), 2.33 (2H, s, CH2C), 1.21
(6H, s, 2-Me). – 13C NMR (75 MHz, CDCl3): δ = 192.05,
1
Yellow solid. – H NMR (300 MHz, CDCl3): δ = 8.39–
156.07, 154.24, 152.13, 135.30, 134.58, 134.10, 133.67, 8.19 (4H, m, Ph), 7.90–7.89 (2H, m, Ph), 7.63–7.60 (2H,
130.85, 130.68, 130.18, 128.94, 128.49, 128.05, 127.62, m, Ph), 6.51(1H, s, CHN), 3.60–3.32 (2H, AB system, J =
127.50, 116.11, 64.43, 50.77, 37.95, 34.56, 28.70, 28.40.
19.23 Hz, CHaHbCO), 2.48–2.36 (2H, m), 2.33–2.27 (2H,
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 11/19/15 8:38 AM